Publication at Third Faculty of Medicine |
2023
Abstract
Atopic dermatitis is a chronic inflammatory skin disease that affects both children and adults. It is characterized by intense itching, redness, and scaling of the skin.
The pathogenesis of atopic dermatitis involves complex interactions between genetic, immunological, and environmental factors. JAK inhibitors are a new class of drugs that target the Janus kinase (JAK) signaling pathway, which plays a key role in the pathogenesis of atopic dermatitis.
JAK inhibitors have been shown to effectively reduce inflammation in a variety of inflammatory diseases, including atopic dermatitis.